141 related articles for article (PubMed ID: 38236640)
21. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.
Yang S; He C; Fan X; Ding W; Wu X; Li J
J Vasc Interv Radiol; 2015 Jul; 26(7):1009-17. PubMed ID: 25921970
[TBL] [Abstract][Full Text] [Related]
22. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
Florescu MM; Costache A; Iacob SM; Pietrareanu C; Ester C; Cerban R; Dumitru R; Grasu M; Lupescu I; Gheorghe L
J Gastrointestin Liver Dis; 2021 Sep; 30(3):374-379. PubMed ID: 34551038
[TBL] [Abstract][Full Text] [Related]
27. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis.
Ng CH; Tan DJH; Nistala KRY; Syn N; Xiao J; Tan EXX; Woo FZ; Chew NWS; Huang DQ; Dan YY; Sanyal AJ; Muthiah MD
Hepatol Int; 2021 Oct; 15(5):1196-1206. PubMed ID: 34417718
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
[TBL] [Abstract][Full Text] [Related]
29. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding.
Spaander MC; Hoekstra J; Hansen BE; Van Buuren HR; Leebeek FW; Janssen HL
J Thromb Haemost; 2013 Mar; 11(3):452-9. PubMed ID: 23289370
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
[TBL] [Abstract][Full Text] [Related]
32. Management of portal vein thrombosis in liver cirrhosis.
Qi X; Han G; Fan D
Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266
[TBL] [Abstract][Full Text] [Related]
33. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
Wu W; Zhang H; Zeng Z; Wang X; Kong D
Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.
Martens K; McMurry HS; Koprowski S; Hum J; Haraga J; Jou JH; Shatzel JJ
J Clin Gastroenterol; 2022 Jul; 56(6):536-545. PubMed ID: 35537133
[TBL] [Abstract][Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
Tadokoro T; Tani J; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Fujita K; Nomura T; Morishita A; Kobara H; Himoto T; Ono M; Masaki T
Sci Rep; 2024 May; 14(1):10784. PubMed ID: 38734732
[TBL] [Abstract][Full Text] [Related]
37. Predictors of insufficient recanalization and portal hypertensive complications after treatment of non-cirrhotic, non-malignant portal vein thrombosis - a population-based study.
Lemma A; Åberg F; Mäkisalo H; Vikatmaa P; Mentula P; Leppäniemi A; Sallinen V
Scand J Gastroenterol; 2020 Nov; 55(11):1324-1332. PubMed ID: 32976739
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
[TBL] [Abstract][Full Text] [Related]
39. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
Gîrleanu I; Trifan A; Stanciu C; Sfarti C
World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
